All posts by: Michael Zand

About Michael Zand

Immunotherapy Combo Shows Early Efficacy for Malignant Mesothelioma – Surviving Mesothelioma

Continue reading

2018-05-25 NEWS

Surviving Mesothelioma

Immunotherapy Combo Shows Early Efficacy for Malignant Mesothelioma
Surviving Mesothelioma
AstraZeneca’s immunotherapy drug tremelimumab may still have a chance as a novel mesothelioma treatment, even though an international clinical trial completed last year found that it did not extend mesothelioma survival. In a new study published in The …

Continue reading

2018-05-25 NEWS

Surviving Mesothelioma

Immunotherapy Combo Shows Early Efficacy for Malignant Mesothelioma
Surviving Mesothelioma
AstraZeneca’s immunotherapy drug tremelimumab may still have a chance as a novel mesothelioma treatment, even though an international clinical trial completed last year found that it did not extend mesothelioma survival. In a new study published in The …

Continue reading

2018-05-24 NEWS

PLoS Blogs (blog)

A New Goal for Gene Therapy: Pet Contraception
PLoS Blogs (blog)
Might gene therapy provide a one-time, far less invasive way to ensure that cats and dogs do not beget kittens and puppies? That’s one of the goals of the Alliance for Contraception in Cats & Dogs. I’ll be speaking at their annual meeting in July